{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:57:55Z","timestamp":1793383075926,"version":"4.5.0"},"reference-count":297,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T00:00:00Z","timestamp":1719446400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ageing Research Reviews"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.arr.2024.102383","type":"journal-article","created":{"date-parts":[[2024,6,30]],"date-time":"2024-06-30T01:27:33Z","timestamp":1719710853000},"page":"102383","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":79,"special_numbering":"C","title":["True or false? Alzheimer\u2019s disease is type 3 diabetes: Evidences from bench to bedside"],"prefix":"10.1016","volume":"99","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8390-7668","authenticated-orcid":false,"given":"Yong","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun-yu","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao-qiao","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-hui","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arr.2024.102383_bib1","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.brainres.2018.09.015","article-title":"Identification of insulin-regulated aminopeptidase (IRAP) in the rat pineal gland and the modulation of melatonin synthesis by angiotensin IV","volume":"1704","author":"Abrah\u00e3o","year":"2019","journal-title":"Brain Res."},{"key":"10.1016\/j.arr.2024.102383_bib2","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.neurobiolaging.2013.10.076","article-title":"Neuroprotective effects of the amylin analogue pramlintide on Alzheimer's disease pathogenesis and cognition","volume":"35","author":"Adler","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.arr.2024.102383_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.physbeh.2022.113767","article-title":"Neurobehavioral and neurobiochemical effect of atomoxetine and N-acetylcysteine in streptozotocin diabetes induced endothelial dysfunction and related dementia","volume":"249","author":"Aggarwal","year":"2022","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.arr.2024.102383_bib4","doi-asserted-by":"crossref","first-page":"E156","DOI":"10.1152\/ajpendo.00642.2020","article-title":"Insulin action in the brain regulates both central and peripheral functions","volume":"321","author":"Agrawal","year":"2021","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.arr.2024.102383_bib5","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s12035-012-8352-z","article-title":"Overlapped metabolic and therapeutic links between Alzheimer and diabetes","volume":"47","author":"Ahmad","year":"2013","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.arr.2024.102383_bib6","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1007\/s00221-018-5341-0","article-title":"Dihydrolipoamide dehydrogenase suppression induces human tau phosphorylation by increasing whole body glucose levels in a C. elegans model of Alzheimer's Disease","volume":"236","author":"Ahmad","year":"2018","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.arr.2024.102383_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2022.109100","article-title":"Glucose enrichment impair neurotransmission and induce A\u03b2 oligomerization that cannot be reversed by manipulating O-\u03b2-GlcNAcylation in the C. elegans model of Alzheimer's disease","volume":"108","author":"Ahmad","year":"2022","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.arr.2024.102383_bib8","doi-asserted-by":"crossref","first-page":"5427","DOI":"10.1007\/s12035-016-0085-y","article-title":"Metformin attenuates A\u03b2 pathology mediated through levamisole sensitive nicotinic acetylcholine receptors in a C. elegans model of Alzheimer's disease","volume":"54","author":"Ahmad","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.arr.2024.102383_bib9","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.exger.2018.04.021","article-title":"5-Methoxyindole-2-carboxylic acid (MICA) suppresses A\u03b2-mediated pathology in C. elegans","volume":"108","author":"Ahmad","year":"2018","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.arr.2024.102383_bib10","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.gendis.2020.08.004","article-title":"Suppression of a core metabolic enzyme dihydrolipoamide dehydrogenase (dld) protects against amyloid beta toxicity in C. elegans model of Alzheimer's disease","volume":"8","author":"Ahmad","year":"2021","journal-title":"Genes Dis."},{"key":"10.1016\/j.arr.2024.102383_bib11","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s12929-017-0379-z","article-title":"Oxidative toxicity in diabetes and Alzheimer's disease: mechanisms behind ROS\/ RNS generation","volume":"24","author":"Ahmad","year":"2017","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.arr.2024.102383_bib12","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1177\/1535370217711440","article-title":"Ameliorating effect of anti-Alzheimer's drugs on the bidirectional association between type 2 diabetes mellitus and Alzheimer's disease","volume":"242","author":"Ahmed","year":"2017","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.arr.2024.102383_bib13","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/bs.pmbts.2016.12.019","article-title":"Mitochondrial perturbation in Alzheimer's disease and diabetes","author":"Akhter","year":"2017","journal-title":"Mol. Biol. Aging"},{"key":"10.1016\/j.arr.2024.102383_bib14","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.2174\/092986710791331086","article-title":"RAGE: a multi-ligand receptor unveiling novel insights in health and disease","volume":"17","author":"Alexiou","year":"2010","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.arr.2024.102383_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0134648","article-title":"Antidiabetic effect of galantamine: novel effect for a known centrally acting drug","volume":"10","author":"Ali","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.arr.2024.102383_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2023.105326","article-title":"Evidence of disturbed insulin signaling in animal models of Alzheimer's disease","volume":"152","author":"Alves","year":"2023","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.arr.2024.102383_bib17","doi-asserted-by":"crossref","first-page":"5136","DOI":"10.1038\/s41598-018-22985-4","article-title":"Altered insulin\/insulin-like growth factor signaling in a comorbid rat model of ischemia and \u03b2-amyloid toxicity","volume":"8","author":"Amtul","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2024.102383_bib18","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrneurol.2017.185","article-title":"Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums","volume":"14","author":"Arnold","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.arr.2024.102383_bib19","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrneurol.2017.185","article-title":"Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums","volume":"14","author":"Arnold","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.arr.2024.102383_bib20","first-page":"53","article-title":"The role of insulin resistance and glucose metabolism dysregulation in the development of Alzheimer\u00b4s disease","volume":"68","author":"Arrieta-Cruz","year":"2016","journal-title":"Rev. Invest. Clin.; Organo Hosp. Enferm. Nutr."},{"key":"10.1016\/j.arr.2024.102383_bib21","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1001\/archneur.61.5.661","article-title":"Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function","volume":"61","author":"Arvanitakis","year":"2004","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.arr.2024.102383_bib22","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.neubiorev.2016.03.005","article-title":"Diabetes and Alzheimer's disease crosstalk","volume":"64","author":"Baglietto-Vargas","year":"2016","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.arr.2024.102383_bib23","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1001\/archneurol.2010.225","article-title":"Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes","volume":"68","author":"Baker","year":"2011","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.arr.2024.102383_bib24","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1159\/000097202","article-title":"Passage of cytokines across the blood-brain barrier","volume":"2","author":"Banks","year":"1995","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.arr.2024.102383_bib25","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1021\/acschemneuro.7b00410","article-title":"Advanced glycation end products modulate amyloidogenic APP processing and tau phosphorylation: a mechanistic link between glycation and the development of Alzheimer\u2019s disease","volume":"9","author":"Batkulwar","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.arr.2024.102383_bib26","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/YCO.0000000000000140","article-title":"Inflammation and neurodegenerative disorders: is there still hope for therapeutic intervention?","volume":"28","author":"Baune","year":"2015","journal-title":"Curr. Opin. Psychiatry"},{"key":"10.1016\/j.arr.2024.102383_bib27","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2337\/diab.40.4.405","article-title":"Role of oxidative stress in development of complications in diabetes","volume":"40","author":"Baynes","year":"1991","journal-title":"Diabetes"},{"key":"10.1016\/j.arr.2024.102383_bib28","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.expneurol.2007.11.009","article-title":"Prominently decreased hippocampal neurogenesis in a spontaneous model of type 1 diabetes, the nonobese diabetic mouse","volume":"210","author":"Beauquis","year":"2008","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.arr.2024.102383_bib29","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1126\/science.6262917","article-title":"Somatomedin-C mediates growth hormone negative feedback by effects on both the hypothalamus and the pituitary","volume":"212","author":"Berelowitz","year":"1981","journal-title":"Science"},{"key":"10.1016\/j.arr.2024.102383_bib30","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0304-3940(99)00135-4","article-title":"Insulin-degrading enzyme in the Alzheimer's disease brain: prominent localization in neurons and senile plaques","volume":"263","author":"Bernstein","year":"1999","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.arr.2024.102383_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108027","article-title":"SCR-1693 inhibits tau phosphorylation and improves insulin resistance associated cognitive deficits","volume":"168","author":"Bi","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.arr.2024.102383_bib32","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1210\/endo-119-2-943","article-title":"Identification of binding sites for an insulin-like growth factor (IGF-I) in the median eminence of the rat brain by quantitative autoradiography","volume":"119","author":"Bohannon","year":"1986","journal-title":"Endocrinology"},{"key":"10.1016\/j.arr.2024.102383_bib33","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1172\/JCI57256","article-title":"An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease- associated A\u03b2 oligomers","volume":"122","author":"Bomfim","year":"2012","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.arr.2024.102383_bib34","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/jnc.12380","article-title":"Dysregulation of leptin signaling in Alzheimer disease: evidence for neuronal leptin resistance","volume":"128","author":"Bonda","year":"2014","journal-title":"J. Neurochem."},{"key":"10.1016\/j.arr.2024.102383_bib35","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1111\/j.1582-4934.2011.01318.x","article-title":"Possible implications of insulin resistance and glucose metabolism in Alzheimer's disease pathogenesis","volume":"15","author":"Bosco","year":"2011","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.arr.2024.102383_bib36","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.metabol.2019.04.009","article-title":"Corrigendum to \"The BACE1 product sAPP\u03b2 induces ER stress and inflammation and impairs insulin signaling\" [Metab Clin Exp 85 (2018) 59\u201375]","volume":"96","author":"Botteri","year":"2019","journal-title":"Metab.: Clin. Exp."},{"key":"10.1016\/j.arr.2024.102383_bib37","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0168-8227(01)00266-2","article-title":"Dementia and its associations in type 2 diabetes mellitus: the Fremantle Diabetes Study","volume":"53","author":"Bruce","year":"2001","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.arr.2024.102383_bib38","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/ana.20474","article-title":"Mitochondrial abnormalities in Alzheimer brain: mechanistic implications","volume":"57","author":"Bubber","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.arr.2024.102383_bib39","doi-asserted-by":"crossref","unstructured":"Bunn,\u00a0F., Burn,\u00a0A.M., Goodman,\u00a0C., Robinson,\u00a0L., Rait,\u00a0G., et al., 2016. Health services and delivery research. In: Comorbidity and Dementia: A Mixed-method Study on Improving Health Care for People with Dementia (CoDem). NIHR Journals Library, Southampton (UK).","DOI":"10.3310\/hsdr04080"},{"key":"10.1016\/j.arr.2024.102383_bib40","first-page":"661","article-title":"The TOMMORROW study: design of an Alzheimer's disease delay-of-onset clinical trial","volume":"5","author":"Burns","year":"2019","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2024.102383_bib41","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1038\/s41598-019-39828-5","article-title":"Cross-disease analysis of Alzheimer's disease and type-2 Diabetes highlights the role of autophagy in the pathophysiology of two highly comorbid diseases","volume":"9","author":"Caberlotto","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2024.102383_bib42","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.3390\/ph5101103","article-title":"Mitochondria-targeted antioxidant SS31 prevents amyloid beta-induced mitochondrial abnormalities and synaptic degeneration in Alzheimer's disease","volume":"5","author":"Calkins","year":"2012","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.arr.2024.102383_bib43","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.11124\/JBISRIR-2017-003380","article-title":"Metformin and Alzheimer's disease, dementia and cognitive impairment: a systematic review protocol","volume":"15","author":"Campbell","year":"2017","journal-title":"JBI Database Syst. Rev. Implement. Rep."},{"key":"10.1016\/j.arr.2024.102383_bib44","first-page":"4030","article-title":"Brain GLP-1\/IGF-1 signaling and autophagy mediate exendin-4 protection against apoptosis in type 2 diabetic rats","volume":"55","author":"Candeias","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.arr.2024.102383_bib45","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/syn.20863","article-title":"Impact of STZ-induced hyperglycemia and insulin-induced hypoglycemia in plasma amino acids and cortical synaptosomal neurotransmitters","volume":"65","author":"Cardoso","year":"2010","journal-title":"Synapse"},{"key":"10.1016\/j.arr.2024.102383_bib46","doi-asserted-by":"crossref","DOI":"10.3390\/nu12020382","article-title":"Metabolic and cognitive effects of ranolazine in type 2 diabetes mellitus: data from an in vivo model","volume":"12","author":"Cassano","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.arr.2024.102383_bib47","doi-asserted-by":"crossref","first-page":"60","DOI":"10.4158\/EP.12.S1.60","article-title":"Oxidative stress and diabetes-associated complications","volume":"12\u00a0Suppl. 1","author":"Ceriello","year":"2006","journal-title":"Endocr. Pract."},{"key":"10.1016\/j.arr.2024.102383_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0034929","article-title":"Mitochondria-specific accumulation of amyloid \u03b2 induces mitochondrial dysfunction leading to apoptotic cell death","volume":"7","author":"Cha","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.arr.2024.102383_bib49","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.3233\/JAD-190864","article-title":"An exploratory phase IIa study of the PPAR delta\/gamma agonist T3D-959 assessing metabolic and cognitive function in subjects with mild to moderate Alzheimer's disease","volume":"73","author":"Chamberlain","year":"2020","journal-title":"J. Alzheimer's\u00a0Dis.: JAD"},{"key":"10.1016\/j.arr.2024.102383_bib50","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.tins.2022.03.001","article-title":"Insulin action in the brain: cell types, circuits, and diseases","volume":"45","author":"Chen","year":"2022","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.arr.2024.102383_bib51","article-title":"Loss of insulin signaling in astrocytes exacerbates Alzheimer-like phenotypes in a 5xFAD mouse model","volume":"120","author":"Chen","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.arr.2024.102383_bib52","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1073\/pnas.94.6.2295","article-title":"Stat5 is a physiological substrate of the insulin receptor","volume":"94","author":"Chen","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.arr.2024.102383_bib53","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.pneurobio.2013.06.004","article-title":"Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies","volume":"108","author":"Chen","year":"2013","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.arr.2024.102383_bib54","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s10072-017-3166-4","article-title":"Matrix metalloproteinase 14 modulates diabetes and Alzheimer's disease cross-talk: a meta-analysis","volume":"39","author":"Cheng","year":"2018","journal-title":"Neurol. Sci.: Off. J. Ital. Neurol. Soc. Ital. Soc. Clin. Neurophysiol."},{"key":"10.1016\/j.arr.2024.102383_bib55","doi-asserted-by":"crossref","first-page":"665","DOI":"10.2147\/DDDT.S348055","article-title":"The role of glucagon-like peptide-1 receptor agonists (GLP-1 RA) in diabetes-related neurodegenerative diseases","volume":"16","author":"Cheng","year":"2022","journal-title":"Drug Des.\u00a0Dev. Ther."},{"key":"10.1016\/j.arr.2024.102383_bib56","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.neurobiolaging.2007.07.008","article-title":"Identification and characterization of an insulin receptor substrate 4-interacting protein in rat brain: implications for longevity","volume":"30","author":"Chiba","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.arr.2024.102383_bib57","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.neuron.2008.04.014","article-title":"Insulin receptor signaling regulates synapse number, dendritic plasticity, and circuit function in vivo","volume":"58","author":"Chiu","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.arr.2024.102383_bib58","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.jdiacomp.2017.01.006","article-title":"Effects of pioglitazone on the incidence of dementia in patients with diabetes","volume":"31","author":"Chou","year":"2017","journal-title":"J. Diabetes Complicat."},{"key":"10.1016\/j.arr.2024.102383_bib59","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1007\/s00125-013-2904-2","article-title":"Insulin resistance in type 1 diabetes: what is 'double diabetes' and what are the risks?","volume":"56","author":"Cleland","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/j.arr.2024.102383_bib60","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.93340","article-title":"Galantamine alleviates inflammation and insulin resistance in patients with metabolic syndrome in a randomized trial","volume":"2","author":"Consolim-Colombo","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.arr.2024.102383_bib61","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1007\/s00415-004-0649-z","article-title":"The neuroprotective role of inflammation in nervous system injuries","volume":"251","author":"Correale","year":"2004","journal-title":"J. Neurol."},{"key":"10.1016\/j.arr.2024.102383_bib62","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.brainres.2011.12.063","article-title":"Insulin signaling, glucose metabolism and mitochondria: major players in Alzheimer's disease and diabetes interrelation","volume":"1441","author":"Correia","year":"2012","journal-title":"Brain Res."},{"key":"10.1016\/j.arr.2024.102383_bib63","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/nrneurol.2012.112","article-title":"Insulin resistance and AD\u2014extending the translational path","volume":"8","author":"Craft","year":"2012","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.arr.2024.102383_bib64","doi-asserted-by":"crossref","DOI":"10.1001\/archneurol.2011.233","article-title":"Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment","volume":"69","author":"Craft","year":"2012","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.arr.2024.102383_bib65","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2020.1840","article-title":"Safety, efficacy, and feasibility of intranasal insulin for the treatment of mild cognitive impairment and Alzheimer disease dementia","volume":"77","author":"Craft","year":"2020","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.arr.2024.102383_bib66","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/s12967-018-1612-6","article-title":"Large-scale in silico identification of drugs exerting sex-specific effects in the heart","volume":"16","author":"Cui","year":"2018","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.arr.2024.102383_bib67","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1007\/s11682-016-9583-9","article-title":"Cerebral perfusion alterations in type 2 diabetes and its relation to insulin resistance and cognitive dysfunction","volume":"11","author":"Cui","year":"2017","journal-title":"Brain Imaging Behav."},{"key":"10.1016\/j.arr.2024.102383_bib68","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1148\/radiol.2503080751","article-title":"Mild cognitive impairment and alzheimer disease: patterns of altered cerebral blood flow at MR imaging","volume":"250","author":"Dai","year":"2009","journal-title":"Radiology"},{"key":"10.1016\/j.arr.2024.102383_bib69","doi-asserted-by":"crossref","first-page":"12502","DOI":"10.1074\/jbc.271.21.12502","article-title":"Cloning and characterization of GRB14, a novel member of the GRB7 gene family","volume":"271","author":"Daly","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2024.102383_bib70","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s10517-021-05191-7","article-title":"Oxidative stress: pathogenetic role in diabetes mellitus and its complications and therapeutic approaches to correction","volume":"171","author":"Darenskaya","year":"2021","journal-title":"Bull. Exp. Biol. Med."},{"key":"10.1016\/j.arr.2024.102383_bib71","doi-asserted-by":"crossref","first-page":"657","DOI":"10.3233\/JAD-180906","article-title":"Early-stage Alzheimer's disease is associated with simultaneous systemic and central nervous system dysregulation of insulin-linked metabolic pathways","volume":"68","author":"de la Monte","year":"2019","journal-title":"J. Alzheimer's\u00a0Dis.: JAD"},{"key":"10.1016\/j.arr.2024.102383_bib72","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1177\/193229680800200619","article-title":"Alzheimer's disease is type 3 diabetes-evidence reviewed","volume":"2","author":"de la Monte","year":"2008","journal-title":"J. Diabetes Sci. Technol."},{"key":"10.1016\/j.arr.2024.102383_bib73","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1007\/s00125-003-1235-0","article-title":"Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRI","volume":"46","author":"den Heijer","year":"2003","journal-title":"Diabetologia"},{"key":"10.1016\/j.arr.2024.102383_bib74","doi-asserted-by":"crossref","first-page":"8445","DOI":"10.1016\/S0021-9258(17)37214-9","article-title":"Insulin gene expression and insulin synthesis in mammalian neuronal cells","volume":"269","author":"Devaskar","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2024.102383_bib75","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/jnc.15166","article-title":"Alzheimer's disease and type 2 diabetes mellitus: a systematic review of proteomic studies","volume":"156","author":"Diniz Pereira","year":"2021","journal-title":"J. Neurochem."},{"key":"10.1016\/j.arr.2024.102383_bib76","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.neurobiolaging.2012.08.003","article-title":"Leptin prevents hippocampal synaptic disruption and neuronal cell death induced by amyloid \u03b2","volume":"34","author":"Doherty","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.arr.2024.102383_bib77","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/ar.1092070108","article-title":"Insulin- and glucagonlike peptides in the brain","volume":"207","author":"Dorn","year":"1983","journal-title":"Anat. Rec."},{"key":"10.1016\/j.arr.2024.102383_bib78","first-page":"304","article-title":"Metabolic alterations associated to brain dysfunction in diabetes","volume":"6","author":"Duarte","year":"2015","journal-title":"Aging Dis."},{"key":"10.1016\/j.arr.2024.102383_bib79","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s10517-012-1529-7","article-title":"Effect of combination therapy with coenzyme Q10 on functional and metabolic parameters in patients with type 1 diabetes mellitus","volume":"152","author":"Dzugkoev","year":"2012","journal-title":"Bull. Exp. Biol. Med."},{"key":"10.1016\/j.arr.2024.102383_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2020.101095","article-title":"Crosstalk between obesity, diabetes, and alzheimer's disease: introducing quercetin as an effective triple herbal medicine","volume":"62","author":"Ebrahimpour","year":"2020","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.arr.2024.102383_bib81","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0891-0618(02)00058-3","article-title":"Expression of insulin-responsive glucose transporter GLUT4 mRNA in the rat brain and spinal cord: an in situ hybridization study","volume":"24","author":"El Messari","year":"2002","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.arr.2024.102383_bib82","doi-asserted-by":"crossref","first-page":"246","DOI":"10.2174\/1568026619666190201152153","article-title":"PTP1b inhibition, a promising approach for the treatment of diabetes type II","volume":"19","author":"Eleftheriou","year":"2019","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.arr.2024.102383_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114772","article-title":"Memantine mitigates ROS\/TXNIP\/NLRP3 signaling and protects against mouse diabetic retinopathy: histopathologic, ultrastructural and bioinformatic studies","volume":"163","author":"ElSayed","year":"2023","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.arr.2024.102383_bib84","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/bs.irn.2020.03.018","article-title":"A role for sodium glucose cotransporter 2 inhibitors (SGLT2is) in the treatment of Alzheimer's disease?","volume":"155","author":"Esterline","year":"2020","journal-title":"Int Rev Neurobiol"},{"key":"10.1016\/j.arr.2024.102383_bib85","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.3233\/JAD-181240","article-title":"Metformin Improves Learning and Memory in the SAMP8 Mouse Model of Alzheimer's Disease","volume":"68","author":"Farr","year":"2019","journal-title":"Journal of Alzheimer's disease:JAD"},{"key":"10.1016\/j.arr.2024.102383_bib86","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.neuropharm.2017.12.001","article-title":"Insulin-mediated synaptic plasticity in the CNS: anatomical, functional and temporal contexts","volume":"136","author":"Ferrario","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.arr.2024.102383_bib87","doi-asserted-by":"crossref","first-page":"830","DOI":"10.3389\/fnins.2018.00830","article-title":"Insulin resistance in Alzheimer's disease","volume":"12","author":"Ferreira","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.arr.2024.102383_bib88","doi-asserted-by":"crossref","first-page":"E255","DOI":"10.1038\/ncb1101-e255","article-title":"Organelle-specific initiation of cell death pathways","volume":"3","author":"Ferri","year":"2001","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.arr.2024.102383_bib89","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1096\/fj.04-2572com","article-title":"Obesity-related leptin regulates Alzheimer's Abeta","volume":"18","author":"Fewlass","year":"2004","journal-title":"FASEB J.: Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"10.1016\/j.arr.2024.102383_bib90","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.2337\/diab.42.9.1253","article-title":"Counterregulation during hypoglycemia is directed by widespread brain regions","volume":"42","author":"Frizzell","year":"1993","journal-title":"Diabetes"},{"key":"10.1016\/j.arr.2024.102383_bib91","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1523\/JNEUROSCI.21-08-02561.2001","article-title":"Stimulation of beta-amyloid precursor protein trafficking by insulin reduces intraneuronal beta-amyloid and requires mitogen-activated protein kinase signaling","volume":"21","author":"Gasparini","year":"2001","journal-title":"J. Neurosci.: Off. J. Soc. Neurosci."},{"key":"10.1016\/j.arr.2024.102383_bib92","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.regpep.2006.06.004","article-title":"Role of endogenous amylin in glucagon secretion and gastric emptying in rats demonstrated with the selective antagonist, AC187","volume":"137","author":"Gedulin","year":"2006","journal-title":"Regul. Pept."},{"key":"10.1016\/j.arr.2024.102383_bib93","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3233\/JAD-170522","article-title":"Association of cerebrospinal fluid (CSF) insulin with cognitive performance and CSF biomarkers of Alzheimer's disease","volume":"61","author":"Geijselaers","year":"2018","journal-title":"J. Alzheimer's\u00a0Dis.: JAD"},{"key":"10.1016\/j.arr.2024.102383_bib94","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.cell.2005.05.011","article-title":"Electron transfer between cytochrome c and p66Shc generates reactive oxygen species that trigger mitochondrial apoptosis","volume":"122","author":"Giorgio","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.arr.2024.102383_bib95","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/fcp.12585","article-title":"Evaluation of the neuroprotective effect of donepezil in type 2 diabetic rats","volume":"35","author":"Gomaa","year":"2021","journal-title":"Fundam. Clin. Pharm."},{"key":"10.1016\/j.arr.2024.102383_bib96","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/jne.12138","article-title":"Protective effect of leptin and ghrelin against toxicity induced by amyloid-\u03b2 oligomers in a hypothalamic cell line","volume":"26","author":"Gomes","year":"2014","journal-title":"J. Neuroendocr."},{"key":"10.1016\/j.arr.2024.102383_bib97","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mce.2015.12.015","article-title":"Blockade of cannabinoid 1 receptor improves GLP-1R mediated insulin secretion in mice","volume":"423","author":"Gonz\u00e1lez-Mariscal","year":"2016","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.arr.2024.102383_bib98","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1210\/endo-114-4-1187","article-title":"Characterization of insulin-like growth factor receptors in rat anterior pituitary, hypothalamus, and brain","volume":"114","author":"Goodyer","year":"1984","journal-title":"Endocrinology"},{"key":"10.1016\/j.arr.2024.102383_bib99","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1474-4422(18)30028-0","article-title":"Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study","volume":"17","author":"Gordon","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.arr.2024.102383_bib100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2016.10.004","article-title":"Tau hyperphosphorylation in the brain of ob\/ob mice is due to hypothermia: importance of thermoregulation in linking diabetes and Alzheimer's disease","volume":"98","author":"Gratuze","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.arr.2024.102383_bib101","doi-asserted-by":"crossref","first-page":"46359","DOI":"10.1038\/srep46359","article-title":"Insulin deprivation induces PP2A inhibition and tau hyperphosphorylation in hTau mice, a model of Alzheimer's disease-like tau pathology","volume":"7","author":"Gratuze","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2024.102383_bib102","article-title":"Chronic leptin supplementation ameliorates pathology and improves cognitive performance in a transgenic mouse model of Alzheimer's disease","author":"Greco","year":"2009","journal-title":"J. Alzheimer's Dis.: JAD"},{"key":"10.1016\/j.arr.2024.102383_bib103","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s12264-012-1270-2","article-title":"Mitochondrial dysfunction and cellular metabolic deficiency in Alzheimer\u2019s disease","volume":"28","author":"Gu","year":"2012","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.arr.2024.102383_bib104","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/jdi.12087","article-title":"Diabetes mellitus and risk of dementia: a meta-analysis of prospective observational studies","volume":"4","author":"Gudala","year":"2013","journal-title":"J. Diabetes Investig."},{"key":"10.1016\/j.arr.2024.102383_bib105","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.neures.2010.08.012","article-title":"Impaired neural stem\/progenitor cell proliferation in streptozotocin-induced and spontaneous diabetic mice","volume":"68","author":"Guo","year":"2010","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.arr.2024.102383_bib106","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.neuropharm.2011.01.033","article-title":"Peripheral insulin-sensitizer drug metformin ameliorates neuronal insulin resistance and Alzheimer's-like changes","volume":"60","author":"Gupta","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.arr.2024.102383_bib107","doi-asserted-by":"crossref","first-page":"702","DOI":"10.2119\/molmed.2015.00142","article-title":"Galantamine attenuates type 1 diabetes and inhibits anti-insulin antibodies in nonobese diabetic mice","volume":"21","author":"Hanes","year":"2015","journal-title":"Mol. Med."},{"key":"10.1016\/j.arr.2024.102383_bib108","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.neuroscience.2021.03.009","article-title":"SLC40A1 mediates ferroptosis and cognitive dysfunction in type 1 diabetes","volume":"463","author":"Hao","year":"2021","journal-title":"Neuroscience"},{"key":"10.1016\/j.arr.2024.102383_bib109","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2174\/18715273113126660139","article-title":"Insulin-degrading enzyme: a link between Alzheimer's and type 2 diabetes mellitus","volume":"13","author":"Haque","year":"2014","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.arr.2024.102383_bib110","doi-asserted-by":"crossref","first-page":"592","DOI":"10.2174\/156720511796391935","article-title":"Rosiglitazone does not improve cognition or global function when used as adjunctive therapy to AChE inhibitors in mild-to-moderate Alzheimer's disease: two phase 3 studies","volume":"8","author":"Harrington","year":"2011","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.arr.2024.102383_bib111","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/272827a0","article-title":"Insulin receptors are widely distributed in the central nervous system of the rat","volume":"272","author":"Havrankova","year":"1978","journal-title":"Nature"},{"key":"10.1016\/j.arr.2024.102383_bib112","doi-asserted-by":"crossref","first-page":"5737","DOI":"10.1073\/pnas.75.11.5737","article-title":"Identification of insulin in rat brain","volume":"75","author":"Havrankova","year":"1978","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.arr.2024.102383_bib113","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0163-7827(90)90002-3","article-title":"The role of alterations in membrane lipid composition in enabling physiological adaptation of organisms to their physical environment","volume":"29","author":"Hazel","year":"1990","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.arr.2024.102383_bib114","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1093\/brain\/awh452","article-title":"Acute treatment with the PPARgamma agonist pioglitazone and ibuprofen reduces glial inflammation and Abeta1-42 levels in APPV717I transgenic mice","volume":"128","author":"Heneka","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.arr.2024.102383_bib115","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13195-020-00607-4","article-title":"Empagliflozin reduces vascular damage and cognitive impairment in a mixed murine model of Alzheimer's disease and type 2 diabetes","volume":"12","author":"Hierro-Bujalance","year":"2020","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.arr.2024.102383_bib116","doi-asserted-by":"crossref","first-page":"784","DOI":"10.2337\/diacare.26.3.784","article-title":"Pramlintide as an adjunct to insulin therapy improves long-term glycemic and weight control in patients with type 2 diabetes: a 1-year randomized controlled trial","volume":"26","author":"Hollander","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.arr.2024.102383_bib117","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3389\/fnagi.2019.00088","article-title":"Insulin signaling impairment in the brain as a risk factor in Alzheimer's disease","volume":"11","author":"H\u00f6lscher","year":"2019","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.arr.2024.102383_bib118","doi-asserted-by":"crossref","first-page":"4368","DOI":"10.1073\/pnas.81.14.4368","article-title":"Identification of glucagon receptors in rat brain","volume":"81","author":"Hoosein","year":"1984","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.arr.2024.102383_bib119","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.3233\/JAD-160110","article-title":"Insulin resistance is associated with increased levels of cerebrospinal fluid biomarkers of Alzheimer\u2019s disease and reduced memory function in at-risk healthy middle-aged adults","volume":"52","author":"Hoscheidt","year":"2016","journal-title":"J. Alzheimer's\u00a0Dis."},{"key":"10.1016\/j.arr.2024.102383_bib120","first-page":"7668","article-title":"The protective effect of Metformin\/Donepezil in diabetic mice brain: evidence from bioinformatics analysis and experiments","volume":"25","author":"Hou","year":"2021","journal-title":"Eur. Rev. Med. Pharm. Sci."},{"key":"10.1016\/j.arr.2024.102383_bib121","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/978-1-4419-8969-7_8","article-title":"Causes and consequences of disturbances of cerebral glucose metabolism in sporadic Alzheimer disease: therapeutic implications","volume":"541","author":"Hoyer","year":"2004","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.arr.2024.102383_bib122","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1080\/10286020.2011.650885","article-title":"Activation of ERK1\/2-CREB pathway during potentiating synaptic transmission of (-)clausenamide in rat dentate gyrus","volume":"14","author":"Hu","year":"2012","journal-title":"J. Asian Nat. Prod. Res."},{"key":"10.1016\/j.arr.2024.102383_bib123","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.7150\/thno.51666","article-title":"Activation of N-methyl-d-aspartate receptor regulates insulin sensitivity and lipid metabolism","volume":"11","author":"Huang","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.arr.2024.102383_bib124","doi-asserted-by":"crossref","first-page":"a008946","DOI":"10.1101\/cshperspect.a008946","article-title":"The insulin receptor: both a prototypical and atypical receptor tyrosine kinase","volume":"5","author":"Hubbard","year":"2013","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.arr.2024.102383_bib125","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1080\/13543776.2019.1655542","article-title":"Protein tyrosine phosphatase 1B (PTP1B) inhibitors as potential anti-diabetes agents: patent review (2015\u20132018)","volume":"29","author":"Hussain","year":"2019","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.arr.2024.102383_bib126","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-15503-5","article-title":"Vanillin affects amyloid aggregation and non-enzymatic glycation in human insulin","volume":"7","author":"Iannuzzi","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2024.102383_bib127","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1186\/s13104-018-3715-9","article-title":"Memantine has no effect on K(ATP) channels in pancreatic \u03b2 cells","volume":"11","author":"Imai","year":"2018","journal-title":"BMC Res. Notes"},{"key":"10.1016\/j.arr.2024.102383_bib128","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/j.1532-5415.2012.03916.x","article-title":"Metformin, other antidiabetic drugs, and risk of Alzheimer's disease: a population-based case-control study","volume":"60","author":"Imfeld","year":"2012","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.arr.2024.102383_bib129","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/ana.23956","article-title":"Amylin deposition in the brain: a second amyloid in Alzheimer disease?","volume":"74","author":"Jackson","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.arr.2024.102383_bib130","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25052592","article-title":"The bioactivity and phytochemicals of Muscari comosum (Leopoldia comosa), a plant of multiple pharmacological activities","volume":"25","author":"Jaiswal","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2024.102383_bib131","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1096\/fj.09-146308","article-title":"Increased superoxide in vivo accelerates age-associated muscle atrophy through mitochondrial dysfunction and neuromuscular junction degeneration","volume":"24","author":"Jang","year":"2010","journal-title":"FASEB J.: Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"10.1016\/j.arr.2024.102383_bib132","doi-asserted-by":"crossref","first-page":"139","DOI":"10.21101\/cejph.a7238","article-title":"Is Alzheimer's disease a type 3 diabetes? A review","volume":"30","author":"Janoutov\u00e1","year":"2022","journal-title":"Cent. Eur. J. Public Health"},{"key":"10.1016\/j.arr.2024.102383_bib133","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/ddr.21579","article-title":"Cognitive dysfunction: a growing link between diabetes and Alzheimer's disease","volume":"81","author":"Jash","year":"2020","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.arr.2024.102383_bib134","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ajpath.2010.11.022","article-title":"Actions of \u03b2-amyloid protein on human neurons are expressed through the amylin receptor","volume":"178","author":"Jhamandas","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.arr.2024.102383_bib135","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1002\/jnr.21787","article-title":"Defective insulin signaling pathway and increased glycogen synthase kinase-3 activity in the brain of diabetic mice: parallels with Alzheimer's disease and correction by insulin","volume":"86","author":"Jolivalt","year":"2008","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.arr.2024.102383_bib136","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.cardiores.2004.12.020","article-title":"Protection in the aged heart: preventing the heart-break of old age?","volume":"66","author":"Juhaszova","year":"2005","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.arr.2024.102383_bib137","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.mito.2010.09.014","article-title":"Protective effect of N-acetylcysteine supplementation on mitochondrial oxidative stress and mitochondrial enzymes in cerebral cortex of streptozotocin-treated diabetic rats","volume":"11","author":"Kamboj","year":"2011","journal-title":"Mitochondrion"},{"key":"10.1016\/j.arr.2024.102383_bib138","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.bbadis.2016.08.018","article-title":"Is Alzheimer's disease a Type 3 Diabetes? A critical appraisal","volume":"1863","author":"Kandimalla","year":"2017","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.arr.2024.102383_bib139","doi-asserted-by":"crossref","first-page":"26026","DOI":"10.1074\/jbc.273.40.26026","article-title":"Identification of the rat adapter Grb14 as an inhibitor of insulin actions","volume":"273","author":"Kasus-Jacobi","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2024.102383_bib140","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1111\/j.1471-4159.2007.04930.x","article-title":"Kinase activities increase during the development of tauopathy in htau mice","volume":"103","author":"Kelleher","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.arr.2024.102383_bib141","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s00210-019-01616-3","article-title":"Combined vildagliptin and memantine treatment downregulates expression of amyloid precursor protein, and total and phosphorylated tau in a rat model of combined Alzheimer's disease and type 2 diabetes","volume":"392","author":"Khalaf","year":"2019","journal-title":"Naunyn Schmiede. Arch. Pharm."},{"key":"10.1016\/j.arr.2024.102383_bib142","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2174\/1570159X20666220411083922","article-title":"Strategies for treatment of disease-associated dementia beyond Alzheimer's disease: an update","volume":"21","author":"Khan","year":"2023","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.arr.2024.102383_bib143","doi-asserted-by":"crossref","first-page":"21830","DOI":"10.1073\/pnas.0912793107","article-title":"Biguanide metformin acts on tau phosphorylation via mTOR\/protein phosphatase 2A (PP2A) signaling","volume":"107","author":"Kickstein","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.arr.2024.102383_bib144","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.bbrc.2017.09.090","article-title":"Identification of transketolase as a target of PARIS in substantia nigra","volume":"493","author":"Kim","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.arr.2024.102383_bib145","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1006\/bbrc.1998.9981","article-title":"Increased expression of cyclooxygenases and peroxisome proliferator-activated receptor-gamma in Alzheimer's disease brains","volume":"254","author":"Kitamura","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.arr.2024.102383_bib146","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.2337\/dc06-0243","article-title":"Brain aging in very old men with type 2 diabetes: the Honolulu-Asia Aging Study","volume":"29","author":"Korf","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.arr.2024.102383_bib147","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2019.104400","article-title":"Direct effects of antipsychotic drugs on insulin, energy sensing and inflammatory pathways in hypothalamic mouse neurons","volume":"109","author":"Kowalchuk","year":"2019","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.arr.2024.102383_bib148","first-page":"433","article-title":"The role of peripheral inflammatory markers in dementia and Alzheimer's disease: a meta-analysis","volume":"68","author":"Koyama","year":"2013","journal-title":"J. Gerontol. Ser. A\u00a0Biol. Sci. Med. Sci."},{"key":"10.1016\/j.arr.2024.102383_bib149","doi-asserted-by":"crossref","first-page":"5152","DOI":"10.1167\/iovs.07-0427","article-title":"Effect of memantine on neuroretinal function and retinal vascular changes of streptozotocin-induced diabetic rats","volume":"48","author":"Kusari","year":"2007","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.arr.2024.102383_bib150","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.molmet.2016.06.011","article-title":"Insulin in the nervous system and the mind: functions in metabolism, memory, and mood","volume":"5","author":"Lee","year":"2016","journal-title":"Mol. Metab."},{"key":"10.1016\/j.arr.2024.102383_bib151","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.neurobiolaging.2011.02.003","article-title":"AGEs induce Alzheimer-like tau pathology and memory deficit via RAGE-mediated GSK-3 activation","volume":"33","author":"Li","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.arr.2024.102383_bib152","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3233\/JAD-2012-120349","article-title":"Dietary intakes of vitamin E, vitamin C, and \u03b2-carotene and risk of Alzheimer's disease: a meta-analysis","volume":"31","author":"Li","year":"2012","journal-title":"J. Alzheimer's Dis.: JAD"},{"key":"10.1016\/j.arr.2024.102383_bib153","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2147\/CIA.S74042","article-title":"Link between type 2 diabetes and Alzheimer's disease: from epidemiology to mechanism and treatment.","volume":"10","author":"Li","year":"2015","journal-title":"Clin. Interv. Aging"},{"key":"10.1016\/j.arr.2024.102383_bib154","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.2147\/NDT.S111298","article-title":"Type 2 diabetes mellitus might be a risk factor for mild cognitive impairment progressing to Alzheimer's disease.","volume":"12","author":"Li","year":"2016","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.arr.2024.102383_bib155","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13661","article-title":"Sensitivity of the S1 neuronal calcium network to insulin and Bay-K 8644 in vivo: relationship to gait, motivation, and aging processes","volume":"21","author":"Lin","year":"2022","journal-title":"Aging Cell"},{"key":"10.1016\/j.arr.2024.102383_bib156","first-page":"912","article-title":"SGLT2 inhibitors and lower limb complications: an updated meta-analysis","volume":"20","author":"Lin","year":"2021","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.arr.2024.102383_bib157","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S1056-8727(01)00143-X","article-title":"Pathophysiology of oxidative stress in diabetes mellitus","volume":"15","author":"Lipinski","year":"2001","journal-title":"J. Diabetes Complicat."},{"key":"10.1016\/j.arr.2024.102383_bib158","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41401-018-0152-1","article-title":"Identification of novel mouse and rat CB1R isoforms and in silico modeling of human CB1R for peripheral cannabinoid therapeutics","volume":"40","author":"Liu","year":"2019","journal-title":"Acta Pharm. Sin."},{"key":"10.1016\/j.arr.2024.102383_bib159","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/path.2912","article-title":"Deficient brain insulin signalling pathway in Alzheimer's disease and diabetes","volume":"225","author":"Liu","year":"2011","journal-title":"J. Pathol."},{"key":"10.1016\/j.arr.2024.102383_bib160","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-39191-5","article-title":"Distribution of insulin in trigeminal nerve and brain after intranasal administration","volume":"9","author":"Lochhead","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2024.102383_bib161","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.molmet.2018.01.013","article-title":"Insulin-like growth factor receptor signaling regulates working memory, mitochondrial metabolism, and amyloid-\u03b2 uptake in astrocytes","volume":"9","author":"Logan","year":"2018","journal-title":"Mol. Metab."},{"key":"10.1016\/j.arr.2024.102383_bib162","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/2315106","article-title":"Metformin ameliorates A\u03b2 pathology by insulin-degrading enzyme in a transgenic mouse model of Alzheimer's disease","volume":"2020","author":"Lu","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.arr.2024.102383_bib163","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1093\/aje\/154.7.635","article-title":"Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort","volume":"154","author":"Luchsinger","year":"2001","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.arr.2024.102383_bib164","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1586\/14789450.2015.1104251","article-title":"Hyperamylinemia as a risk factor for accelerated cognitive decline in diabetes","volume":"12","author":"Ly","year":"2015","journal-title":"Expert Rev. Proteom."},{"key":"10.1016\/j.arr.2024.102383_bib165","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/13813455.2019.1673434","article-title":"The effect of resveratrol on advanced glycation end products in diabetes mellitus: a systematic review","volume":"128","author":"Maleki","year":"2022","journal-title":"Arch. Physiol. Biochem."},{"key":"10.1016\/j.arr.2024.102383_bib166","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jcim.2c01597","article-title":"Phosphorylation at Ser289 enhances the oligomerization of tau repeat R2","author":"Man","year":"2023","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.arr.2024.102383_bib167","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.freeradbiomed.2016.01.006","article-title":"Ascorbic acid supplementation improves skeletal muscle oxidative stress and insulin sensitivity in people with type 2 diabetes: findings of a randomized controlled study","volume":"93","author":"Mason","year":"2016","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.arr.2024.102383_bib168","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JAD-160761","article-title":"Cholinergic modification of neurogenesis and gliosis improves the memory of A\u03b2PPswe\/PSEN1dE9 Alzheimer's disease model mice fed a high-fat diet","volume":"56","author":"Matsuda","year":"2017","journal-title":"J. Alzheimer's\u00a0Dis.: JAD"},{"key":"10.1016\/j.arr.2024.102383_bib169","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/8953015","article-title":"Proteomic analysis of hippocampus and cortex in streptozotocin-induced diabetic model mice showing dementia","volume":"2018","author":"Matsuura","year":"2018","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.arr.2024.102383_bib170","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/sj.cdd.4401837","article-title":"Roles for NF-kappaB in nerve cell survival, plasticity, and disease","volume":"13","author":"Mattson","year":"2006","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.arr.2024.102383_bib171","first-page":"395","article-title":"Alzheimer's genetic risk intensifies neurocognitive slowing associated with diabetes in non-demented older adults","volume":"1","author":"McFall","year":"2015","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2024.102383_bib172","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.nlm.2010.02.002","article-title":"Hippocampal memory processes are modulated by insulin and high-fat-induced insulin resistance","volume":"93","author":"McNay","year":"2010","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.arr.2024.102383_bib173","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.nlm.2011.08.005","article-title":"Brain insulin signaling: A key component of cognitive processes and a potential basis for cognitive impairment in type 2 diabetes","volume":"96","author":"McNay","year":"2011","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.arr.2024.102383_bib174","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1038\/s41467-018-03755-2","article-title":"The beta secretase BACE1 regulates the expression of insulin receptor in the liver","volume":"9","author":"Meakin","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.arr.2024.102383_bib175","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1146\/annurev-psych-113011-143739","article-title":"The endocannabinoid system and the brain","volume":"64","author":"Mechoulam","year":"2013","journal-title":"Annu. Rev. Psychol."},{"key":"10.1016\/j.arr.2024.102383_bib176","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/nri.2017.66","article-title":"Mitochondrial control of immunity: beyond ATP","volume":"17","author":"Mehta","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.arr.2024.102383_bib177","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-42665-2","article-title":"Galantamine improves glycemic control and diabetic nephropathy in Lepr(db\/db) mice","volume":"13","author":"Meng","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2024.102383_bib178","doi-asserted-by":"crossref","DOI":"10.1186\/s13578-022-00768-9","article-title":"Causal association evaluation of diabetes with Alzheimer's disease and genetic analysis of antidiabetic drugs against Alzheimer's disease","volume":"12","author":"Meng","year":"2022","journal-title":"Cell Biosci."},{"key":"10.1016\/j.arr.2024.102383_bib179","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23052687","article-title":"Alzheimer's disease as type 3 diabetes: common pathophysiological mechanisms between Alzheimer's disease and type 2 diabetes","volume":"23","author":"Michailidis","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2024.102383_bib180","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/46311","article-title":"The p66shc adaptor protein controls oxidative stress response and life span in mammals","volume":"402","author":"Migliaccio","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.arr.2024.102383_bib181","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1017\/S1092852900016886","article-title":"Metabolic syndrome and Alzheimer's disease: a link to a vascular hypothesis?","volume":"13","author":"Milionis","year":"2008","journal-title":"CNS Spectr."},{"key":"10.1016\/j.arr.2024.102383_bib182","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.advms.2017.05.005","article-title":"Endogenous non-enzymatic antioxidants in the human body","volume":"63","author":"Miro\u0144czuk-Chodakowska","year":"2018","journal-title":"Adv. Med. Sci."},{"key":"10.1016\/j.arr.2024.102383_bib183","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1523\/JNEUROSCI.4082-13.2014","article-title":"GABAergic neurogliaform cells represent local sources of insulin in the cerebral cortex","volume":"34","author":"Moln\u00e1r","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.arr.2024.102383_bib184","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.2337\/dc13-0229","article-title":"Increased risk of cognitive impairment in patients with diabetes is associated with metformin","volume":"36","author":"Moore","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.arr.2024.102383_bib185","doi-asserted-by":"crossref","first-page":"4248","DOI":"10.1523\/JNEUROSCI.4640-14.2016","article-title":"Brain-wide insulin resistance, tau phosphorylation changes, and hippocampal neprilysin and amyloid-\u03b2 alterations in a monkey model of type 1 diabetes","volume":"36","author":"Morales-Corraliza","year":"2016","journal-title":"J. Neurosci.: Off. J. Soc. Neurosci."},{"key":"10.1016\/j.arr.2024.102383_bib186","doi-asserted-by":"crossref","first-page":"492","DOI":"10.2174\/187152709789824651","article-title":"Mitochondria as a therapeutic target in Alzheimer's disease and diabetes","volume":"8","author":"Moreira","year":"2009","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.arr.2024.102383_bib187","doi-asserted-by":"crossref","first-page":"S199","DOI":"10.3233\/JAD-2011-111127","article-title":"Alzheimer's disease and diabetes: an integrative view of the role of mitochondria, oxidative stress, and insulin","volume":"30","author":"Moreira","year":"2012","journal-title":"J. Alzheimer's\u00a0Dis."},{"key":"10.1016\/j.arr.2024.102383_bib188","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1038\/mp.2016.230","article-title":"Molecular interaction between type 2 diabetes and Alzheimer's disease through cross-seeding of protein misfolding","volume":"22","author":"Moreno-Gonzalez","year":"2017","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.arr.2024.102383_bib189","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1038\/s41598-020-60664-5","article-title":"Amylin and pramlintide modulate \u03b3-secretase level and APP processing in lipid rafts","volume":"10","author":"Mousa","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2024.102383_bib190","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1755-5949.2010.00172.x","article-title":"Neuropsychiatric adverse effects of centrally acting antiobesity drugs","volume":"17","author":"Nathan","year":"2011","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.arr.2024.102383_bib191","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21093165","article-title":"Type 3 diabetes and its role implications in Alzheimer's disease","volume":"21","author":"Nguyen","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2024.102383_bib192","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1007\/s11064-020-03031-0","article-title":"Role of insulin resistance in the Alzheimer's disease progression","volume":"45","author":"Nguyen","year":"2020","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.arr.2024.102383_bib193","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1007\/s11064-020-03031-0","article-title":"Role of insulin resistance in the Alzheimer's disease progression","volume":"45","author":"Nguyen","year":"2020","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.arr.2024.102383_bib194","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1021\/np400533h","article-title":"Protein tyrosine phosphatase 1B (PTP1B) inhibitors from Morinda citrifolia (Noni) and their insulin mimetic activity","volume":"76","author":"Nguyen","year":"2013","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.arr.2024.102383_bib195","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jpba.2014.11.019","article-title":"Chemical profiling with HPLC-FTMS of exogenous and endogenous chemicals susceptible to the administration of chotosan in an animal model of type 2 diabetes-induced dementia","volume":"104","author":"Niu","year":"2015","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.arr.2024.102383_bib196","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.101979","article-title":"Antidiabetic agents as a novel treatment for Alzheimer's and Parkinson's disease","volume":"89","author":"Nowell","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.arr.2024.102383_bib197","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s40200-020-00541-0","article-title":"Metformin\/Donepezil combination modulates brain antioxidant status and hippocampal endoplasmic reticulum stress in type 2 diabetic rats","volume":"19","author":"Obafemi","year":"2020","journal-title":"J. Diabetes Metab. Disord."},{"key":"10.1016\/j.arr.2024.102383_bib198","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0117362","article-title":"Diabetes mellitus accelerates A\u03b2 pathology in brain accompanied by enhanced GA\u03b2 generation in nonhuman primates","volume":"10","author":"Okabayashi","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.arr.2024.102383_bib199","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0001-2998(71)81033-4","article-title":"Clinical applications of brain blood flow studies","volume":"1","author":"Oldendorf","year":"1971","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.arr.2024.102383_bib200","doi-asserted-by":"crossref","first-page":"10035","DOI":"10.1074\/jbc.272.15.10035","article-title":"Interaction of MAD2 with the carboxyl terminus of the insulin receptor but not with the IGFIR. Evidence for release from the insulin receptor after activation","volume":"272","author":"O'Neill","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2024.102383_bib201","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1212\/WNL.53.9.1937","article-title":"Diabetes mellitus and the risk of dementia: the Rotterdam Study","volume":"53","author":"Ott","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2024.102383_bib202","first-page":"351","article-title":"Metformin treatment prevents amyloid plaque deposition and memory impairment in APP\/PS1 mice","volume":"69","author":"Ou","year":"2018","journal-title":"Brain\u00a0Behav.\u00a0Immun."},{"key":"10.1016\/j.arr.2024.102383_bib203","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1111\/j.1464-5491.2008.02493.x","article-title":"Addressing insulin resistance in Type 1 diabetes","volume":"25","author":"Pang","year":"2008","journal-title":"Diabet. Med.: a J. Br. Diabet. Assoc."},{"key":"10.1016\/j.arr.2024.102383_bib204","doi-asserted-by":"crossref","first-page":"4666","DOI":"10.4049\/jimmunol.0803392","article-title":"IL-13-induced oxidative stress via microglial NADPH oxidase contributes to death of hippocampal neurons in vivo","volume":"183","author":"Park","year":"2009","journal-title":"J. Immunol. (Baltim.\u00a0Md.: 1950)"},{"key":"10.1016\/j.arr.2024.102383_bib205","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2023.1206572","article-title":"Current and future therapeutic strategies for Alzheimer's disease: an overview of drug development bottlenecks","volume":"15","author":"Peng","year":"2023","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.arr.2024.102383_bib206","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.ejphar.2019.04.038","article-title":"Diabetic retinopathy: focus on NADPH oxidase and its potential as therapeutic target","volume":"853","author":"Peng","year":"2019","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.arr.2024.102383_bib207","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1385\/JMN:23:1-2:097","article-title":"Cell degeneration induced by amyloid-beta peptides: implications for Alzheimer's disease","volume":"23","author":"Pereira","year":"2004","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.arr.2024.102383_bib208","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.3233\/JAD-161050","article-title":"Plasma amyloid-\u03b2 peptides in type 2 diabetes: a matched case-control study","volume":"56","author":"Peters","year":"2017","journal-title":"J. Alzheimer's\u00a0Dis."},{"key":"10.1016\/j.arr.2024.102383_bib209","doi-asserted-by":"crossref","first-page":"89","DOI":"10.59566\/IJBS.2008.4089","article-title":"Free radicals, antioxidants in disease and health","volume":"4","author":"Pham-Huy","year":"2008","journal-title":"Int. J. Biomed. Sci."},{"key":"10.1016\/j.arr.2024.102383_bib210","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1016","article-title":"Recent novel approaches to limit oxidative stress and inflammation in diabetic complications","volume":"7","author":"Pickering","year":"2018","journal-title":"Clin. Transl. Immunol."},{"key":"10.1016\/j.arr.2024.102383_bib211","article-title":"Association between metformin and neurodegenerative diseases of observational studies: systematic review and meta-analysis","volume":"8","author":"Ping","year":"2020","journal-title":"BMJ Open Diabetes Res.\u00a0Care"},{"key":"10.1016\/j.arr.2024.102383_bib212","doi-asserted-by":"crossref","DOI":"10.3390\/nu11081837","article-title":"Curcumin and type 2 diabetes mellitus: prevention and treatment","volume":"11","author":"Pivari","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.arr.2024.102383_bib213","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1023\/A:1022457605436","article-title":"Regional membrane phospholipid alterations in Alzheimer's disease","volume":"23","author":"Prasad","year":"1998","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.arr.2024.102383_bib214","doi-asserted-by":"crossref","first-page":"357","DOI":"10.2165\/00002512-200623050-00001","article-title":"Transdermal treatment options for neurological disorders: impact on the elderly","volume":"23","author":"Priano","year":"2006","journal-title":"Drugs Aging"},{"key":"10.1016\/j.arr.2024.102383_bib215","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/WAD.0000000000000172","article-title":"Diabetes, hemoglobin A1C, and regional Alzheimer disease and infarct pathology","volume":"31","author":"Pruzin","year":"2017","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.arr.2024.102383_bib216","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.bbadis.2016.04.017","article-title":"Common neurodegenerative pathways in obesity, diabetes, and Alzheimer's disease","volume":"1863","author":"Pugazhenthi","year":"2017","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.arr.2024.102383_bib217","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/jnc.13497","article-title":"Regulation of cyclic AMP response element-binding protein during neuroglial interactions","volume":"136","author":"Qin","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.arr.2024.102383_bib218","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.neurobiolaging.2005.01.004","article-title":"Insulin, insulin-degrading enzyme and amyloid-beta peptide in Alzheimer's disease: review and hypothesis","volume":"27","author":"Qiu","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.arr.2024.102383_bib219","doi-asserted-by":"crossref","first-page":"32730","DOI":"10.1074\/jbc.273.49.32730","article-title":"Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation","volume":"273","author":"Qiu","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2024.102383_bib220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0089229","article-title":"Central proliferation and neurogenesis is impaired in type 2 diabetes and prediabetes animal models","volume":"9","author":"Ramos-Rodriguez","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.arr.2024.102383_bib221","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1111\/j.1464-5491.2004.01319.x","article-title":"Amylin replacement with pramlintide as an adjunct to insulin therapy improves long-term glycaemic and weight control in Type 1 diabetes mellitus: a 1-year, randomized controlled trial","volume":"21","author":"Ratner","year":"2004","journal-title":"Diabet. Med."},{"key":"10.1016\/j.arr.2024.102383_bib222","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1089\/15209150252924094","article-title":"Adjunctive therapy with the amylin analogue pramlintide leads to a combined improvement in glycemic and weight control in insulin-treated subjects with type 2 diabetes","volume":"4","author":"Ratner","year":"2002","journal-title":"Diabetes Technol. Ther."},{"key":"10.1016\/j.arr.2024.102383_bib223","article-title":"Therapeutic advantages of dual targeting of PPAR-\u03b4 and PPAR-\u03b3 in an experimental model of sporadic Alzheimer's disease","volume":"5","author":"Reich","year":"2018","journal-title":"J. Park. Dis. Alzheimers Dis."},{"key":"10.1016\/j.arr.2024.102383_bib224","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1523\/JNEUROSCI.2120-19.2019","article-title":"Neuronal protein tyrosine phosphatase 1B hastens amyloid \u03b2-associated Alzheimer's disease in mice","volume":"40","author":"Ricke","year":"2020","journal-title":"J. Neurosci.: Off. J. Soc. Neurosci."},{"key":"10.1016\/j.arr.2024.102383_bib225","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.2337\/dc07-0589","article-title":"Pramlintide improved glycemic control and reduced weight in patients with type 2 diabetes using basal insulin","volume":"30","author":"Riddle","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.arr.2024.102383_bib226","first-page":"246","article-title":"Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease","volume":"6","author":"Risner","year":"2006","journal-title":"Pharm. J."},{"key":"10.1016\/j.arr.2024.102383_bib227","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0891-5849(99)00264-6","article-title":"Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo","volume":"28","author":"Roberts","year":"2000","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.arr.2024.102383_bib228","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1016\/j.bbagen.2014.05.017","article-title":"Diabetes, oxidative stress and therapeutic strategies","volume":"1840","author":"Rochette","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.arr.2024.102383_bib229","doi-asserted-by":"crossref","first-page":"32957","DOI":"10.1074\/jbc.M507016200","article-title":"High beta-secretase activity elicits neurodegeneration in transgenic mice despite reductions in amyloid-beta levels: implications for the treatment of Alzheimer disease","volume":"280","author":"Rockenstein","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2024.102383_bib230","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.taap.2006.01.003","article-title":"Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress","volume":"212","author":"Rolo","year":"2006","journal-title":"Toxicol. Appl. Pharm."},{"key":"10.1016\/j.arr.2024.102383_bib231","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.biopha.2017.04.057","article-title":"Carotenoids in the treatment of diabetes mellitus and its complications: a mechanistic review","volume":"91","author":"Roohbakhsh","year":"2017","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.arr.2024.102383_bib232","article-title":"Neurometabolic evidence supporting the hypothesis of increased incidence of type 3 diabetes mellitus in the 21st century","volume":"2019","author":"Rorbach-Dolata","year":"2019","journal-title":"BioMed\u00a0Res. Int."},{"key":"10.1016\/j.arr.2024.102383_bib233","doi-asserted-by":"crossref","DOI":"10.3390\/antiox9080683","article-title":"Sex difference impacts on the relationship between paraoxonase-1 (PON1) and type 2 diabetes","volume":"9","author":"Rosta","year":"2020","journal-title":"Antioxidants"},{"key":"10.1016\/j.arr.2024.102383_bib234","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1126\/science.1070058","article-title":"Ablation of insulin-producing neurons in flies: growth and diabetic phenotypes","volume":"296","author":"Rulifson","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.arr.2024.102383_bib235","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117861","article-title":"Metformin loaded phosphatidylserine nanoliposomes improve memory deficit and reduce neuroinflammation in streptozotocin-induced Alzheimer's disease model","volume":"255","author":"Saffari","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.arr.2024.102383_bib236","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/s41591-021-01369-8","article-title":"A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer's disease","volume":"27","author":"Salloway","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.arr.2024.102383_bib237","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2337\/db09-1128","article-title":"Insulin causes hyperthermia by direct inhibition of warm-sensitive neurons","volume":"59","author":"Sanchez-Alavez","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.arr.2024.102383_bib238","doi-asserted-by":"crossref","first-page":"599","DOI":"10.2119\/molmed.2011.00083","article-title":"Galantamine alleviates inflammation and other obesity-associated complications in high-fat diet-fed mice","volume":"17","author":"Satapathy","year":"2011","journal-title":"Mol. Med."},{"key":"10.1016\/j.arr.2024.102383_bib239","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1016\/j.neurobiolaging.2009.10.009","article-title":"Efficacy of PPAR-\u03b3 agonist pioglitazone in mild Alzheimer disease","volume":"32","author":"Sato","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.arr.2024.102383_bib240","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0006-8993(94)90170-8","article-title":"Immunohistochemical and in situ hybridization study of an insulin-like substance in fetal neuron cell cultures","volume":"636","author":"Schechter","year":"1994","journal-title":"Brain Res."},{"key":"10.1016\/j.arr.2024.102383_bib241","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.2337\/dc16-2516","article-title":"Diabetes in a large dementia cohort: clinical characteristics and treatment from the Swedish dementia registry","volume":"40","author":"Secnik","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.arr.2024.102383_bib242","article-title":"Cholinesterase inhibitors in patients with diabetes mellitus and dementia: an open-cohort study of \u223c\u200923,000 patients from the Swedish Dementia Registry","volume":"8","author":"Secnik","year":"2020","journal-title":"BMJ Open Diabetes Res.\u00a0Care"},{"key":"10.1016\/j.arr.2024.102383_bib243","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0306-4522(02)00747-9","article-title":"Association of ATP synthase alpha-chain with neurofibrillary degeneration in Alzheimer's disease","volume":"117","author":"Sergeant","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.arr.2024.102383_bib244","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1210\/jc.2018-01315","article-title":"Cognitive dysfunction in type 1 diabetes mellitus","volume":"104","author":"Shalimova","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.arr.2024.102383_bib245","doi-asserted-by":"crossref","first-page":"983","DOI":"10.7150\/ijbs.66871","article-title":"The role of melatonin in the treatment of type 2 diabetes mellitus and Alzheimer's disease","volume":"18","author":"Shen","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.arr.2024.102383_bib246","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jns.2017.11.031","article-title":"Insulin resistance and cognitive test performance in elderly adults: national health and nutrition examination survey (NHANES)","volume":"388","author":"Sherzai","year":"2018","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.arr.2024.102383_bib247","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-024954","article-title":"Effect of metformin on neurodegenerative disease among elderly adult US veterans with type 2 diabetes mellitus","volume":"9","author":"Shi","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.arr.2024.102383_bib248","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/cns.13201","article-title":"Studies of pathology and pharmacology of diabetic encephalopathy with KK-Ay mouse model","volume":"26","author":"Shi","year":"2020","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.arr.2024.102383_bib249","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.7150\/ijms.72119","article-title":"Risk of peripheral artery disease and stroke in migraineurs with or without aura: a nationwide population-based cohort study","volume":"19","author":"Siao","year":"2022","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.arr.2024.102383_bib250","doi-asserted-by":"crossref","DOI":"10.1042\/AN20130027","article-title":"Identification of Bax-interacting proteins in oligodendrocyte progenitors during glutamate excitotoxicity and perinatal hypoxia-ischemia","volume":"5","author":"Simonishvili","year":"2013","journal-title":"ASN Neuro"},{"key":"10.1016\/j.arr.2024.102383_bib251","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgz234","article-title":"Metformin and risk of Alzheimer's disease among community-dwelling people with diabetes: a national case-control study","volume":"105","author":"Sluggett","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.arr.2024.102383_bib252","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1006\/scbi.1997.0062","article-title":"Rel\/NF-kappa B transcription factors and the control of apoptosis","volume":"8","author":"Sonenshein","year":"1997","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.arr.2024.102383_bib253","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.491","article-title":"Adiponectin controls the apoptosis and the expression of tight junction proteins in brain endothelial cells through AdipoR1 under beta amyloid toxicity","volume":"8","author":"Song","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.arr.2024.102383_bib254","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1084\/jem.20160493","article-title":"Changes in insulin and insulin signaling in Alzheimer\u2019s disease: cause or consequence?","volume":"213","author":"Stanley","year":"2016","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.arr.2024.102383_bib255","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3233\/JAD-2005-7107","article-title":"Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease\u2013is this type 3 diabetes?","volume":"7","author":"Steen","year":"2005","journal-title":"J. Alzheimer's\u00a0Dis.: JAD"},{"key":"10.1016\/j.arr.2024.102383_bib256","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.neurobiolaging.2005.09.021","article-title":"Redox proteomics identification of oxidized proteins in Alzheimer's disease hippocampus and cerebellum: an approach to understand pathological and biochemical alterations in AD","volume":"27","author":"Sultana","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.arr.2024.102383_bib257","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.neurobiolaging.2004.07.010","article-title":"Local expression of GH and IGF-1 in the hippocampus of GH-deficient long-lived mice","volume":"26","author":"Sun","year":"2005","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.arr.2024.102383_bib258","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1177\/0271678X17709709","article-title":"Insulin differentially affects the distribution kinetics of amyloid beta 40 and 42 in plasma and brain","volume":"38","author":"Swaminathan","year":"2018","journal-title":"J. Cereb. Blood Flow\u00a0Metab.: Off. J. Int. Soc. Cereb. Blood Flow\u00a0Metab."},{"key":"10.1016\/j.arr.2024.102383_bib259","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0008-6363(00)00240-6","article-title":"Direct activation of mitochondrial K(ATP) channels mimics preconditioning but protein kinase C activation is less effective in middle-aged rat hearts.","volume":"49","author":"Tani","year":"2001","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.arr.2024.102383_bib260","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1126\/science.6338593","article-title":"Insulin-like growth factors: a role in growth hormone negative feedback and body weight regulation via brain","volume":"220","author":"Tannenbaum","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.arr.2024.102383_bib261","doi-asserted-by":"crossref","first-page":"597","DOI":"10.3233\/JAD-170948","article-title":"Pramlintide: the effects of a single drug injection on blood phosphatidylcholine profile for Alzheimer's disease","volume":"62","author":"Tao","year":"2018","journal-title":"J. Alzheimer's\u00a0Dis.: JAD"},{"key":"10.1016\/j.arr.2024.102383_bib262","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2013.284","article-title":"Glucose intolerance, insulin resistance, and pathological features of Alzheimer disease in the baltimore longitudinal study of aging","volume":"70","author":"Thambisetty","year":"2013","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.arr.2024.102383_bib263","doi-asserted-by":"crossref","DOI":"10.3390\/nu12041032","article-title":"Dietary supplementation with curcumin reduce circulating levels of glycogen synthase kinase-3\u03b2 and islet amyloid polypeptide in adults with high risk of type 2 diabetes and Alzheimer's disease","volume":"12","author":"Thota","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.arr.2024.102383_bib264","doi-asserted-by":"crossref","first-page":"162","DOI":"10.17305\/bjbms.2016.919","article-title":"Apoptosis in pancreatic \u03b2-islet cells in Type 2 diabetes","volume":"16","author":"Tomita","year":"2016","journal-title":"Bosn. J. Basic Med. Sci."},{"key":"10.1016\/j.arr.2024.102383_bib265","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.biocel.2006.07.001","article-title":"Free radicals and antioxidants in normal physiological functions and human disease","volume":"39","author":"Valko","year":"2007","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.arr.2024.102383_bib266","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.nbd.2017.04.005","article-title":"Insulin deficiency results in reversible protein kinase A activation and tau phosphorylation","volume":"103","author":"van der Harg","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.arr.2024.102383_bib267","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2017.06.003","article-title":"Central insulin dysregulation and energy dyshomeostasis in two mouse models of Alzheimer's disease","volume":"58","author":"Velazquez","year":"2017","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.arr.2024.102383_bib268","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.neuropharm.2017.11.014","article-title":"Connecting Alzheimer's disease to diabetes: underlying mechanisms and potential therapeutic targets","volume":"136","author":"Vieira","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.arr.2024.102383_bib269","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3389\/fnagi.2017.00007","article-title":"Protein tyrosine phosphatase 1B (PTP1B): a potential target for Alzheimer's therapy?","volume":"9","author":"Vieira","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.arr.2024.102383_bib270","doi-asserted-by":"crossref","first-page":"510","DOI":"10.2165\/00002512-199404060-00006","article-title":"Tacrine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in Alzheimer's disease","volume":"4","author":"Wagstaff","year":"1994","journal-title":"Drugs Aging"},{"key":"10.1016\/j.arr.2024.102383_bib271","doi-asserted-by":"crossref","first-page":"19318","DOI":"10.1073\/pnas.0804871105","article-title":"Amyloid-beta overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission\/fusion proteins.","volume":"105","author":"Wang","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.arr.2024.102383_bib272","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0962-8924(96)81024-5","article-title":"Insulin receptor substrate 1 and 2 (IRS1 and IRS2): what a tangled web we weave","volume":"6","author":"Waters","year":"1996","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.arr.2024.102383_bib273","first-page":"950","article-title":"Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: a preliminary study","volume":"13","author":"Watson","year":"2005","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.arr.2024.102383_bib274","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2165\/00023210-200317010-00003","article-title":"The role of insulin resistance in the pathogenesis of Alzheimer's disease: implications for treatment","volume":"17","author":"Watson","year":"2003","journal-title":"CNS Drugs"},{"key":"10.1016\/j.arr.2024.102383_bib275","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0212293","article-title":"Association of metformin, sulfonylurea and insulin use with brain structure and function and risk of dementia and Alzheimer's disease: pooled analysis from 5 cohorts","volume":"14","author":"Weinstein","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.arr.2024.102383_bib276","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jns.2016.04.017","article-title":"Blood glucose levels and cortical thinning in cognitively normal, middle-aged adults","volume":"365","author":"Wennberg","year":"2016","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.arr.2024.102383_bib277","doi-asserted-by":"crossref","first-page":"724","DOI":"10.2337\/diacare.25.4.724","article-title":"A randomized study and open-label extension evaluating the long-term efficacy of pramlintide as an adjunct to insulin therapy in type 1 diabetes","volume":"25","author":"Whitehouse","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.arr.2024.102383_bib278","doi-asserted-by":"crossref","first-page":"5409","DOI":"10.1096\/fj.201700431R","article-title":"Amyloid-\u03b2 and islet amyloid pathologies link Alzheimer's disease and type 2 diabetes in a transgenic model","volume":"31","author":"Wijesekara","year":"2017","journal-title":"FASEB J.: Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"10.1016\/j.arr.2024.102383_bib279","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1096\/fj.201701352","article-title":"Tau ablation in mice leads to pancreatic \u03b2 cell dysfunction and glucose intolerance","volume":"32","author":"Wijesekara","year":"2018","journal-title":"FASEB J.: Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"10.1016\/j.arr.2024.102383_bib280","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.bbadis.2008.10.013","article-title":"A look inside the diabetic brain: contributors to diabetes-induced brain aging","volume":"1792","author":"Wrighten","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.arr.2024.102383_bib281","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2022.114969","article-title":"System pharmacology analysis to decipher the effect and mechanism of active ingredients combination from herb couple on rheumatoid arthritis in rats","volume":"288","author":"Wu","year":"2022","journal-title":"Journal of ethnopharmacology"},{"key":"10.1016\/j.arr.2024.102383_bib282","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.clineuro.2018.08.012","article-title":"Low glucagon-like peptide-1 (GLP-1) concentration in serum is indicative of mild cognitive impairment in type 2 diabetes patients","volume":"174","author":"Wu","year":"2018","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.arr.2024.102383_bib283","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.npep.2015.08.009","article-title":"Insulin resistance-induced hyperglycemia decreased the activation of Akt\/CREB in hippocampus neurons: molecular evidence for mechanism of diabetes-induced cognitive dysfunction","volume":"54","author":"Xiang","year":"2015","journal-title":"Neuropeptides"},{"key":"10.1016\/j.arr.2024.102383_bib284","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.neuroscience.2018.06.018","article-title":"Insulin-signaling pathway regulates the degradation of amyloid \u03b2-protein via astrocytes","volume":"385","author":"Yamamoto","year":"2018","journal-title":"Neuroscience"},{"key":"10.1016\/j.arr.2024.102383_bib285","doi-asserted-by":"crossref","first-page":"7504","DOI":"10.1523\/JNEUROSCI.23-20-07504.2003","article-title":"Anti-inflammatory drug therapy alters beta-amyloid processing and deposition in an animal model of Alzheimer's disease","volume":"23","author":"Yan","year":"2003","journal-title":"J. Neurosci.: Off. J. Soc. Neurosci."},{"key":"10.1016\/j.arr.2024.102383_bib286","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s00592-020-01648-9","article-title":"The prevalence of mild cognitive impairment in type 2 diabetes mellitus patients: a systematic review and meta-analysis","volume":"58","author":"You","year":"2021","journal-title":"Acta Diabetol."},{"key":"10.1016\/j.arr.2024.102383_bib287","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0143-4179(86)90035-1","article-title":"Periventricular hypothalamic cells in the rat brain contain insulin mRNA","volume":"8","author":"Young","year":"1986","journal-title":"Neuropeptides"},{"key":"10.1016\/j.arr.2024.102383_bib288","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/cvr\/cvn104","article-title":"Mitochondrial fission mediates high glucose-induced cell death through elevated production of reactive oxygen species","volume":"79","author":"Yu","year":"2008","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.arr.2024.102383_bib289","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/sj.cdd.4401599","article-title":"The voltage-dependent anion channel-1 modulates apoptotic cell death","volume":"12","author":"Zaid","year":"2005","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.arr.2024.102383_bib290","doi-asserted-by":"crossref","first-page":"43617","DOI":"10.18632\/oncotarget.17116","article-title":"Chronic diabetic states worsen Alzheimer neuropathology and cognitive deficits accompanying disruption of calcium signaling in leptin-deficient APP\/PS1 mice","volume":"8","author":"Zhang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.arr.2024.102383_bib291","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00213-015-4133-5","article-title":"A novel acetylcholinesterase inhibitor and calcium channel blocker SCR-1693 improves A\u03b225-35-impaired mouse cognitive function","volume":"233","author":"Zhang","year":"2016","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.arr.2024.102383_bib292","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1254\/jphs.11115FP","article-title":"Diabetes-induced central cholinergic neuronal loss and cognitive deficit are attenuated by tacrine and a Chinese herbal prescription, kangen-karyu: elucidation in type 2 diabetes db\/db mice","volume":"117","author":"Zhao","year":"2011","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.arr.2024.102383_bib293","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/1472-6882-12-188","article-title":"Chotosan ameliorates cognitive and emotional deficits in an animal model of type 2 diabetes: possible involvement of cholinergic and VEGF\/PDGF mechanisms in the brain","volume":"12","author":"Zhao","year":"2012","journal-title":"BMC Complement. Altern. Med."},{"key":"10.1016\/j.arr.2024.102383_bib294","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1007\/s00125-022-05743-0","article-title":"Evaluating the efficacy and mechanism of metformin targets on reducing Alzheimer's disease risk in the general population: a Mendelian randomisation study","volume":"65","author":"Zheng","year":"2022","journal-title":"Diabetologia"},{"key":"10.1016\/j.arr.2024.102383_bib295","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.bbadis.2006.10.014","article-title":"Alzheimer disease, the two-hit hypothesis: an update","volume":"1772","author":"Zhu","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.arr.2024.102383_bib296","first-page":"33","article-title":"An amylin analog used as a challenge test for Alzheimer's disease","volume":"3","author":"Zhu","year":"2017","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2024.102383_bib297","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/mp.2014.17","article-title":"Intraperitoneal injection of the pancreatic peptide amylin potently reduces behavioral impairment and brain amyloid pathology in murine models of Alzheimer's disease","volume":"20","author":"Zhu","year":"2015","journal-title":"Mol. Psychiatry"}],"container-title":["Ageing Research Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163724002010?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163724002010?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T06:59:32Z","timestamp":1722063572000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568163724002010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":297,"alternative-id":["S1568163724002010"],"URL":"https:\/\/doi.org\/10.1016\/j.arr.2024.102383","relation":{},"ISSN":["1568-1637"],"issn-type":[{"value":"1568-1637","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"True or false? Alzheimer\u2019s disease is type 3 diabetes: Evidences from bench to bedside","name":"articletitle","label":"Article Title"},{"value":"Ageing Research Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arr.2024.102383","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102383"}}